Found 1236 clinical trials
COVID-19 Self-Testing Through Rapid Network Distribution (C-STRAND)
COVID-19, the coronavirus disease caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has led to a global pandemic and has exacerbated existing health inequities among
- 0 views
- 29 May, 2022
- 1 location
ACTIV-6: COVID-19 Study of Repurposed Medications
The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate COVID-19
- 357 views
- 04 Oct, 2022
- 93 locations
AGILE (Early Phase Platform Trial for COVID-19)
The AGILE platform master protocol allows incorporation of a range of identified and yet-to-be-identified candidates as potential treatments for adults with COVID-19 into the trial. Candidates
- 122 views
- 07 Oct, 2022
- 3 locations
Developing and Testing a COVID-19 Vaccination Acceptance Intervention (CoVAcS)
The COVID-19 pandemic has resulted in significant loss of life and suffering with total case and death counts increasing daily, particularly with the emergence of the delta variant. COVID-19
- 0 views
- 29 Apr, 2022
- 1 location
Detection of COVID-19 Using Breath Analysis - Validation Study (COVID-19)
DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY
- 0 views
- 04 Oct, 2022
- 1 location
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
To evaluate the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine plus a homologous boostwith Ad26.COV2.S COVID-19 vaccine among Sisonke participants as compared to unboosted
- 43 views
- 04 Oct, 2022
- 31 locations
HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)
HEAL-COVID is jointly Sponsored by Cambridge University Hospitals NHS Foundation Trust and The University of Cambridge. The acute effects of COVID-19 are now well described. Evidence is
- 0 views
- 02 Aug, 2021
- 1 location
A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated (COVID-19)
This trial is a randomized study to evaluate the immunogenicity of COVID-19 Vaccine (Vero Cell), Inactivated and in population aged 60 years old and 3-17 years old with different schedules
- 13 views
- 12 Jul, 2022
- 1 location
National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) (ENFORCE)
National cohort study of effectiveness and safety of SARS-CoV-2 vaccines (ENFORCE is an equivalence trial to evaluate the effectiveness and safety of multiple new SARS-CoV-2 vaccines approved for use in the EU, and which are being offered at participating units. The design is an open-labelled, non-randomised, parallel group, phase IV …
- 40 views
- 26 Apr, 2022
- 5 locations
Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US (C3)
This C3 project, Community network-driven COVID-19 testing of vulnerable populations in the Central US, will implement and evaluate a COVID-19 testing and vaccination approach that combines an
- 0 views
- 10 Apr, 2022
- 1 location